Compugen Company Leadership

CGEN Stock  USD 1.61  0.09  5.92%   
Compugen employs about 68 people. The company is managed by 15 executives with a total tenure of roughly 23 years, averaging almost 1.0 years of service per executive, having 4.53 employees per reported executive. Analysis of Compugen's management performance can provide insight into the firm performance.
Anat CohenDayag  CEO
President CEO, Director
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

Compugen Management Team Effectiveness

The company has return on total asset (ROA) of (0.0304) % which means that it has lost $0.0304 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1584) %, meaning that it created substantial loss on money invested by shareholders. Compugen's management efficiency ratios could be used to measure how well Compugen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of November 2024, Return On Tangible Assets is likely to drop to -0.16. In addition to that, Return On Capital Employed is likely to drop to -0.14. At this time, Compugen's Non Current Assets Total are very stable compared to the past year. As of the 27th of November 2024, Total Current Assets is likely to grow to about 120.3 M, while Total Assets are likely to drop about 70.8 M.
As of the 27th of November 2024, Common Stock Shares Outstanding is likely to drop to about 47.3 M. In addition to that, Net Loss is likely to drop to about (31.8 M)

Compugen Workforce Comparison

Compugen is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 2,986. Compugen holds roughly 68.0 in number of employees claiming about 2.28% of equities under Health Care industry.

Compugen Profit Margins

The company has Profit Margin (PM) of (0.22) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.880.9401
Notably Down
Slightly volatile

Compugen Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Compugen Price Series Summation is a cross summation of Compugen price series and its benchmark/peer.

Compugen Notable Stakeholders

A Compugen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Compugen often face trade-offs trying to please all of them. Compugen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Compugen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Anat CohenDayagPresident CEO, DirectorProfile
Zurit LevineVP of Research and DiscoveryProfile
Alberto SessaChief OfficerProfile
Rivka SchwartzVice DiscoveryProfile
Henry MDSenior OfficerProfile
Eran OphirChief OfficerProfile
Michelle MDChief OfficerProfile
Yvonne NaughtonHead CommunicationsProfile
David CPAChief OfficerProfile
Dorit AmitayVice ResourcesProfile
Eran DorGeneral SecretaryProfile
Oliver FroescheisSr DevelProfile
Pierre FerreVice DevelopmentProfile
Yaron MBASenior SolutionsProfile

About Compugen Management Performance

The success or failure of an entity such as Compugen often depends on how effective the management is. Compugen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Compugen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Compugen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.15)(0.16)
Return On Capital Employed(0.14)(0.14)
Return On Assets(0.15)(0.16)
Return On Equity(0.29)(0.30)

Compugen Workforce Analysis

Traditionally, organizations such as Compugen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Compugen within its industry.

Compugen Manpower Efficiency

Return on Compugen Manpower

Revenue Per Employee492K
Revenue Per Executive2.2M
Net Loss Per Employee275.8K
Net Loss Per Executive1.3M
Working Capital Per Employee1.3M
Working Capital Per Executive5.9M
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.03
Revenue Per Share
0.48
Quarterly Revenue Growth
3.461
Return On Assets
(0.03)
Return On Equity
(0.16)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.